HLTH Cue Health
- 0.1168
- -0.0054-4.42%
Cue Health News
Cue Health Says It Is Evaluating FDA Warning Letter Over COVID-19 Test
Cue Health (HLTH) said late Monday it is evaluating a warning letter it received from the US Food and Drug Administration regarding its Emergency Use Authorized COVID-19 test. "The [c]ompany is curren
Reported Earlier, FDA Issues Warning To Cue Health Over Emergency Use Authorized (EUA) COVID-19 Test
The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.
Cue Health Receives FDA Warning Letter Regarding Emergency Use Authorized COVID-19 Test
FDA Says Inspection Revealed Cue Health Is Not Complying With Some Conditions Of Authorization In Letters Of Authorization For EUA200248 & EUA210180
FDA Says Inspection Revealed Cue Health Is Not Complying With Some Conditions Of Authorization In Letters Of Authorization For EUA200248 & EUA210180
On May 9, Cue Health Got Warning Letter From FDA; Says During Inspection, Investigator Determined Cue Health Markets, Distributes Cue Health Covid-19 Test & Cue Health Covid-19 Test For Home & OTC Use
On May 9, Cue Health Got Warning Letter From FDA; Says During Inspection, Investigator Determined Cue Health Markets, Distributes Cue Health Covid-19 Test & Cue Health Covid-19 Test For Home & OTC Use
Cue Health Evaluating Warning Letter Received From Food and Drug Administration (FDA)
SAN DIEGO--(BUSINESS WIRE)--May 13, 2024-- Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorize
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 25% Cheaper
Unfortunately for some shareholders, the Cue Health Inc. (NASDAQ:HLTH) share price has dived 25% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twelve month
Cue Health to Cut About Half of Workforce
By Ben Glickman Cue Health said on Wednesday it would cut about half of its workforce as it looks to reduce costs and focus on its core technology offering, marking its second round of layoffs this y
Cue Health to Announce First Quarter Financial Results
SAN DIEGO--(BUSINESS WIRE)--Apr. 29, 2024-- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Mo
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
Cue Health Finalizes Separation Terms With Ex-Officer Khattak
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (KZR), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Cue Health (HLTH)
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
To the annoyance of some shareholders, Cue Health Inc. (NASDAQ:HLTH) shares are down a considerable 26% in the last month, which continues a horrid run for the company. For any long-term shareholde
Cue Health's Hold Rating Amidst Leadership Changes and FDA Setbacks
Cue Health Announces Major Leadership Restructuring
Cue Health Reveals Strategic Actions; Names Clint Sever As CEO; Seeks To Refine And Strengthen Its Overarching Strategy And Cost Structure
Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub Khattak, who is stepping down as Chief Executive Officer, President, and C
Cue Health: Khattak to Resign as Chairman, Remain on Board >HLTH
Cue Health: Khattak to Resign as Chairman, Remain on Board >HLTH
Cue Health: Comprehensive Review of Business, Operations to Be Initiated >HLTH
Cue Health: Comprehensive Review of Business, Operations to Be Initiated >HLTH
Analysis
Price Target
No Data
